BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35313869)

  • 1. Comparison of tumor and two types of paratumoral tissues highlighted epigenetic regulation of transcription during field cancerization in non-small cell lung cancer.
    Wang Q; Wu L; Yu J; Li G; Zhang P; Wang H; Shao L; Liu J; Shen W
    BMC Med Genomics; 2022 Mar; 15(1):66. PubMed ID: 35313869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free DNA methylation profile potential in the diagnosis of lung squamous cell carcinoma.
    Du C; Cai J; Tang J; Chen Y; Díaz-Peña R; Tomita Y; Jassem J; Zhao J; Zheng D; Tu Z
    J Thorac Dis; 2024 Jan; 16(1):553-563. PubMed ID: 38410586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
    Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
    Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
    [No Abstract]   [Full Text] [Related]  

  • 4. Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas.
    Carvalho RH; Hou J; Haberle V; Aerts J; Grosveld F; Lenhard B; Philipsen S
    J Thorac Oncol; 2013 May; 8(5):562-73. PubMed ID: 23524404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization.
    Muse ME; Titus AJ; Salas LA; Wilkins OM; Mullen C; Gregory KJ; Schneider SS; Crisi GM; Jawale RM; Otis CN; Christensen BC; Arcaro KF
    Epigenetics; 2020 Oct; 15(10):1093-1106. PubMed ID: 32255732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of enhancer methylation for epigenetic regulation of tumorigenesis in squamous lung cancer.
    Cho JW; Shim HS; Lee CY; Park SY; Hong MH; Lee I; Kim HR
    Exp Mol Med; 2022 Jan; 54(1):12-22. PubMed ID: 34987166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
    Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
    PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-small Cell Lung Cancer Epigenomes Exhibit Altered DNA Methylation in Smokers and Never-smokers.
    Karlow JA; Pehrsson EC; Xing X; Watson M; Devarakonda S; Govindan R; Wang T
    Genomics Proteomics Bioinformatics; 2023 Oct; 21(5):991-1013. PubMed ID: 37742993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer.
    Pangeni RP; Yang L; Zhang K; Wang J; Li W; Guo C; Yun X; Sun T; Wang J; Raz DJ
    Clin Epigenetics; 2020 Jun; 12(1):88. PubMed ID: 32552834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
    Wang Y; Liu D; Jin X; Song H; Lou G
    Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
    Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
    BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.
    Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH
    Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
    Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
    Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.
    Kadara H; Fujimoto J; Yoo SY; Maki Y; Gower AC; Kabbout M; Garcia MM; Chow CW; Chu Z; Mendoza G; Shen L; Kalhor N; Hong WK; Moran C; Wang J; Spira A; Coombes KR; Wistuba II
    J Natl Cancer Inst; 2014 Mar; 106(3):dju004. PubMed ID: 24563515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
    Spitzwieser M; Entfellner E; Werner B; Pulverer W; Pfeiler G; Hacker S; Cichna-Markl M
    BMC Cancer; 2017 Apr; 17(1):260. PubMed ID: 28403857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of G0S2 as a gene frequently methylated in squamous lung cancer by combination of in silico and experimental approaches.
    Kusakabe M; Kutomi T; Watanabe K; Emoto N; Aki N; Kage H; Hamano E; Kitagawa H; Nagase T; Sano A; Yoshida Y; Fukami T; Murakawa T; Nakajima J; Takamoto S; Ota S; Fukayama M; Yatomi Y; Ohishi N; Takai D
    Int J Cancer; 2010 Apr; 126(8):1895-1902. PubMed ID: 19816938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
    Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
    Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Suppression of the T-box Subfamily 2 (
    Nehme E; Rahal Z; Sinjab A; Khalil A; Chami H; Nemer G; Kadara H
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation markers of early-stage non-small cell lung cancer.
    Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
    PLoS One; 2012; 7(6):e39813. PubMed ID: 22768131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.